NCT00004562View on ClinicalTrials.gov

Occluded Artery Trial (OAT)

PHASE3CompletedINTERVENTIONAL
Enrollment

2,201

Participants

Timeline

Start Date

September 30, 1999

Primary Completion Date

March 31, 2010

Study Completion Date

June 30, 2011

Conditions
Cardiovascular DiseasesHeart DiseasesMyocardial InfarctionHeart Failure, CongestiveHeart Failure
Interventions
DRUG

Beta adrenergic blockers

Participants will receive beta adrenergic blockers.

DRUG

Platelet inhibitors

Participants will receive platelet inhibitors.

PROCEDURE

PTCA and stents

Participants will undergo percutaneous coronary intervention (PTCA) and coronary stenting.

DRUG

ACE Inhibitors

Participants will receive ACE inhibitors.

Trial Locations (1)

10010

New York University School of Medicine, New York

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

NYU Langone Health

OTHER

NCT00004562 - Occluded Artery Trial (OAT) | Biotech Hunter | Biotech Hunter